Healthy volunteers test new drug absorption in Early-Stage trial
NCT ID NCT07046715
First seen Nov 17, 2025 · Last updated May 24, 2026 · Updated 17 times
Summary
This study looked at how a new drug (DA-5222) is absorbed by the body when taken alone versus when its three components are taken together. Forty healthy adults each received both treatments in a random order, and researchers measured drug levels in the blood. The goal was purely to gather information on absorption and safety, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bumin Hospital
Seoul, Gangseo-gu, 07590, South Korea
Conditions
Explore the condition pages connected to this study.